Morris, 2012 - Google Patents
Fluorescent biosensors for cancer cell imaging and diagnosticsMorris, 2012
- Document ID
- 5336747868872616767
- Author
- Morris M
- Publication year
- Publication venue
- Biosensors and Cancer
External Links
Snippet
Although cancer represents the leading cause of death worldwide, its burden could be largely reduced through implementation of diagnostic approaches for early detection and strategies to monitor disease progression and response to treatment. The development of …
- 201000011510 cancer 0 title abstract description 111
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0056—Peptides, proteins, polyamino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wang et al. | A highly selective and sensitive chemiluminescent probe for leucine aminopeptidase detection in vitro, in vivo and in human liver cancer tissue | |
| Qian et al. | A mitochondria-targeting and polarity-sensitive fluorescent probe for cancer diagnosis | |
| Huang et al. | Integrin αvβ3-targeted IRDye 800CW near-infrared imaging of glioblastoma | |
| Mochida et al. | Activatable fluorescent probes in fluorescence-guided surgery: Practical considerations | |
| Anees et al. | Real time monitoring of aminothiol level in blood using a near-infrared dye assisted deep tissue fluorescence and photoacoustic bimodal imaging | |
| Zhao et al. | Searching for the optimal fluorophore to label antimicrobial peptides | |
| Zhu et al. | Fluorescence imaging of drug target proteins using chemical probes | |
| Wu et al. | Rapid differentiation between bacterial infections and cancer using a near-infrared fluorogenic probe | |
| Ardeshirpour et al. | In vivo fluorescence lifetime imaging monitors binding of specific probes to cancer biomarkers | |
| Morris | Fluorescent biosensors for cancer cell imaging and diagnostics | |
| Kamiya et al. | Rapid and sensitive fluorescent imaging of tiny tumors in vivo and in clinical specimens | |
| CA2766272C (en) | Soricidin derived peptides and methods for the detection of trpv-6 cancers and drug delivery | |
| Li et al. | Near-infrared fluorescence imaging of CD13 receptor expression using a novel Cy5. 5-labeled dimeric NGR peptide | |
| Chilakamarthi et al. | Synthesis and functional characterization of a fluorescent peptide probe for non invasive imaging of collagen in live tissues | |
| Wu et al. | Rational Design of an Activatable Near‐Infrared Fluorogenic Platform for In Vivo Orthotopic Tumor Imaging and Resection | |
| Ni et al. | Transferrin receptor 1 targeted optical imaging for identifying glioma margin in mouse models | |
| Kazim et al. | Recent Advances in the Development of Non‐Invasive Imaging Probes for Cancer Immunotherapy | |
| Hernandez Vargas et al. | Receptor-targeted fluorescence-guided surgery with low molecular weight agents | |
| Song et al. | A dual-modal nanoprobe based on Eu (III) complex–MnO 2 nanosheet nanocomposites for time-gated luminescence–magnetic resonance imaging of glutathione in vitro and in vivo | |
| Wang et al. | Imaging investigation of hepatocellular carcinoma progress via monitoring γ-glutamyltranspeptidase level with a near-infrared fluorescence/photoacoustic bimodal probe | |
| Boaro et al. | Light-emitting probes for labeling peptides | |
| Gunduz et al. | Directing chemiluminescent dioxetanes to mitochondria: A cationic luminophore enables in vitro and in vivo detection of cancer cells upon enzymatic activation | |
| He et al. | Optical molecular imaging technology and its application in precise surgical navigation of liver cancer | |
| Zhao et al. | Research progresses on the functional polypeptides in the detection and imaging of breast cancer | |
| Xu et al. | Recent Advances of Aminopeptidases‐Responsive Small‐Molecular Probes for Bioimaging |